Drug
Docosahexaenoyl-paclitaxel clinical trials
Also written Taxoprexin and DHA-paclitaxel.
How studies write it
Studies that test it under each name
Studies by the year they started
9 studies that test it; most in 2001 (4)
| Year | Studies |
|---|---|
| 2001 | 4 |
| 2002 | 1 |
| 2005 | 3 |
| 2007 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 9 · Other 0
American Regent, Inc. (5) · Theradex (4)
Related medicines
As reviewed, each with the page that says it.
- One of Antimitotic Agents source
Studies
Open first, then newest update. How each study uses docosahexaenoyl-paclitaxel is read from its arms, and is right about nine times in ten.
Testing it · 9
- Taxoprexin® Treatment for Advanced Eye MelanomaCompletedPhase 2American Regent, Inc.NCT00244816Written as Taxoprexin
- Taxoprexin® Treatment for Advanced Primary Cancers of the Liver, Gallbladder or Biliary TractTerminatedPhase 2American Regent, Inc.NCT00422877Written as Taxoprexin
- Taxoprexin Treatment for Advanced Skin MelanomaCompletedPhase 2American Regent, Inc.NCT00249262Written as Taxoprexin
- Taxoprexin Plus Carboplatin Treatment for Advanced Lung CancerCompletedPhase 3American Regent, Inc.NCT00243867Written as Taxoprexin
- Study of Taxoprexin Injection vs. Dacarbazine in Patients With Metastatic Malignant MelanomaTerminatedPhase 3American Regent, Inc.NCT00087776Written as Taxoprexin
- DHA-Paclitaxel in Treating Patients With Metastatic Pancreatic CancerStatus unknownPhase 2TheradexNCT00024375Written as DHA-paclitaxel
- DHA-Paclitaxel in Treating Patients With Metastatic Prostate CancerStatus unknownPhase 2TheradexNCT00024414Written as DHA-paclitaxel
- DHA-Paclitaxel in Treating Patients With Metastatic Colorectal CancerStatus unknownPhase 2TheradexNCT00024401Written as DHA-paclitaxel
- Chemotherapy in Treating Patients With Metastatic Kidney CancerStatus unknownPhase 2TheradexNCT00024388Written as DHA-paclitaxel
Codes
What other systems call docosahexaenoyl-paclitaxel · ClinicalTrials.gg INT005256
- MeSH (NLM) C528070docosahexaenoyl-paclitaxelConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) OJE5810C4FPACLITAXEL DOCOSAHEXAENOIC ACIDConfirmed FDA, NLM
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C528070 | docosahexaenoyl-paclitaxel | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | OJE5810C4F | PACLITAXEL DOCOSAHEXAENOIC ACID | Confirmed FDA, NLM |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.